 |
Julia Karow tracks trends in next-generation sequencing for research and clinical applications for GenomeWeb's In Sequence and Clinical Sequencing News. E-mail Julia Karow or follow her GenomeWeb Twitter accounts at @InSequence and @ClinSeqNews. |
Sequencing Explains 'Outlier' Patient Response to Everolimus, Shows Promise for Drug Repositioning
September 19, 2012
Sequencing Explains 'Outlier' Patient Response to Everolimus, Shows Promise for Drug Repositioning
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Copy Number Analysis via Exome Sequencing Helps Researchers Time-Stamp Cancer Mutations
July 13, 2011 / Clinical Sequencing News - UCSF, Abbott Partner on New Pathogen Dx Lab
June 15, 2009 / GenomeWeb Daily News - At Investor Confab, Illumina Details 'Enormous' DTC Demand as Market Shifts to Less Complex Chips
May 21, 2013 / BioArray News - ICCG, Awaiting Funding, Moves Ahead with Plans to Build Database of Genomic, Phenotypic Information
May 21, 2013 / BioArray News - Sequencing of Cell-Free DNA Holds Promise for Monitoring Cancer During Treatment, Study Suggests
March 20, 2013 / Clinical Sequencing News